Molecular Target Synopsis
Overview
Domains and Structures
Drugs and Clinical Candidates
Druggability
Chemistry
Ligand Efficiency Plot
Pathways
Family Cladogram
Interaction Network
Gene Expression
Gene Copy Number Variation
RNAi
Mutations
Germline Genetics

TPMT (P51580) - Druggability - Molecular Target Synopsis

Chain-based assessment (last updated 08/10/2019)
Domain-based assessment (last updated 30/07/2012)


Structural Druggability Help: Help

Chain-based assessment (last updated 08/10/2019)


Chains assessed3
Chains with at least one site assessed as druggable using the strict criteria3
Chains with at least one site assessed as druggable using the relaxed criteria3


		
PDB Chain Protein Name Druggable Relaxed Druggable Strict Details
2H11_A Thiopurine S-methyltransferase Yes Yes show/hide
Site num Site Status Pickpocket Polar Ratio Surfnet Gap Vertices Buried Surfnet Long Axis Druggable Relaxed Druggable Strict
1 bound 1.72 77.7 35.1 Yes Yes
2 bound 2.51 70.7 15.6 No No
3 empty 1.95 69.9 17.1 No No
4 bound 2.05 63.3 18.3 No No
5 empty 2.28 58.7 22.5 No No
6 empty 1.81 67.1 11.9 No No
7 empty 2.41 62.6 16.6 No No
8 empty 2.25 65.2 10.3 No No
9 empty 2.12 71.6 9 No No
10 empty 1.76 65 8.3 No No
2BZG_A Thiopurine S-methyltransferase Yes Yes show/hide
Site num Site Status Pickpocket Polar Ratio Surfnet Gap Vertices Buried Surfnet Long Axis Druggable Relaxed Druggable Strict
1 bound 1.69 81.9 34.7 Yes Yes
2 empty 1.95 66.4 16 No No
3 bound 2.39 71 16.4 No No
4 empty 2.34 61.9 25.3 No No
5 empty 2.01 64.5 18.8 No No
6 empty 2.58 60.9 21.4 No No
7 empty 2.03 68.3 11.2 No No
8 empty 2.16 66.5 9.4 No No
9 empty 2.58 70 9.8 No No
10 empty 1.65 57.3 10.9 No No
2H11_B Thiopurine S-methyltransferase Yes Yes show/hide
Site num Site Status Pickpocket Polar Ratio Surfnet Gap Vertices Buried Surfnet Long Axis Druggable Relaxed Druggable Strict
1 bound 1.72 80.3 36.2 Yes Yes
2 empty 2.42 64.7 25.9 No No
3 empty 1.96 68.2 16.7 No No
4 bound 2.56 70.6 15.9 No No
5 empty 2.13 63.2 21.1 No No
6 empty 1.94 64.6 11.4 No No
7 empty 2.52 62.5 14.7 No No
8 empty 2.1 74.6 8 No No
9 empty 2.34 65.1 11.1 No No
10 empty 1.65 61.3 8.7 No No

Domain-based assessment (last updated 30/07/2012)


Domains assessed3
Domains assessed as druggable using the strict criteria3
Domains assessed as druggable using the relaxed criteria3

PDB (Domain) Protein Name Domain Resolution Ligands Druggable Relaxed Druggable Strict
2BZG_A (129559) Thiopurine S-methyltransferase S-adenosyl-L-methionine-dependent methyltransferases, S-adenosyl-L-methionine-dependent methyltransferases, Thiopurine S-methyltransferase 1.58Å Yes Yes
2H11_B (135942) Thiopurine S-methyltransferase S-adenosyl-L-methionine-dependent methyltransferases, S-adenosyl-L-methionine-dependent methyltransferases, Thiopurine S-methyltransferase 1.89Å Yes Yes
2H11_A (135941) Thiopurine S-methyltransferase S-adenosyl-L-methionine-dependent methyltransferases, S-adenosyl-L-methionine-dependent methyltransferases, Thiopurine S-methyltransferase 1.89Å Yes Yes
Ligand-based Druggability Score: -1.75
Ligand-based Druggability Score Percentile: 61%
Ligand-based Druggability Help: Help




		
Number of proteins in the network : 13346


TPMT is involved in 1 interactions in the network.


Druggability
Overall Druggability Percentile: 1.87
Druggability for Cancer Therapeutics: 1.84
Druggability for Other Therapeutics: 1.79
Cancer-Associated
Cancer-associated percentile : 1.28
Network Articulation Point
Is TPMT critical for communication in the network?


Detailed Graph Legend:Help